Chilling effect

Chilling effect

Reda SadkiGlobal health

We reached out to senior decision makers working in global health about the new Certificate peer learning programme for equity in research and practice. Crickets. One CEO wrote: “We aren’t currently in a position to enter into new strategic partnerships on the topic.” The chilling effect is real. Many organizations are retreating from publicly championing equity work—even those with deep commitments to fairness and inclusion. But here’s the opportunity: While public discourse faces headwinds, meaningful work continues through trusted networks and communities of practice. This is precisely when innovation in equity approaches accelerates—away from the spotlight but with profound impact. The evidence is clear: health systems that neglect equity waste resources and deliver poorer outcomes. When research excludes key populations or policies overlook certain communities, we all lose—through inefficiency, increased costs, and diminished impact. This moment calls for courage from those who understand that equity is fundamental to effective health …

WHO Director-General says Immunization Agenda 2030 off-track

Widening inequities: Immunization Agenda 2030 remains “off-track”

Reda SadkiGlobal health

The WHO Director General’s report to the 154th session of the Executive Board on progress towards the Immunization Agenda 2030 (IA2030) goals paints a “sobering picture” of uneven global recovery since COVID-19. As of 2022, 3 out of 7 main impact indicators remain “off-track”, including numbers of zero-dose children, future deaths averted through vaccination, and outbreak control targets. Current evidence indicates substantial acceleration is essential in order to shift indicators out of the “off-track” categories over the next 7 years. While some indicators showed recovery from pandemic backsliding, the report makes clear these improvements are generally insufficient to achieve targets set for 2030. While some indicators have improved from 2021, overall performance still “lags 2019 levels” (para 5). Specifically, global coverage of three childhood DTP vaccine doses rose from 81% in 2021 to 84% in 2022, but remains below the 86% rate achieved in 2019 before the pandemic (para 5). …